Cue Biopharma
52 hedge funds and large institutions have $13M invested in Cue Biopharma in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
64% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 14
Holders
52
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$439K | |
| 2 | +$78.1K | |
| 3 | +$71.9K | |
| 4 |
Renaissance Technologies
New York
|
+$67.3K |
| 5 |
Squarepoint
New York
|
+$61.7K |
Top Sellers
| 1 | -$106K | |
| 2 | -$67.2K | |
| 3 | -$22.7K | |
| 4 |
SM
Salzhauer Michael
|
-$10.9K |
| 5 |
LPL Financial
San Diego,
California
|
-$9.34K |
